This study in up to 20 healthy subjects (including 10 females and 10 males) will use
[11C]carfentanil whole-body PET imaging to examine the CNS and broader systemic opioid
binding and its blockade by the non-selective opioid antagonist naloxone administered
parenterally in 2 scan sessions, which can be done the same day or on different days.